Indoco Remedies intimates of UK-MHRA inspection of Plant 1 at Goa

Receives 7 observations

Indoco Remedies announced that United Kingdom - The Medicines and Healthcare Products Regulatory Agency (UK-MHRA) inspected the company's drug manufacturing facility (Plant 1 in Goa) from 14 March to 16 March 2018.

Subsequent to the inspection, the UK-MHRA issued observations, which include 3 critical and 4 major.

Powered by Capital Market - Live News